Diagnosis of the infectious disease involves identifying the presence of a foreign antigen/organism using diagnostic tools like kits. Most of the currently available standard diagnostic test kits are for bacterial infections and sexually transmitted diseases. In spite of significant improvements in sanitation practices and medicine, the global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV and tuberculosis are considerably high, which drives the market.
According to the report analysis of,’ Global infectious disease test device market to reach USD 26.8 billion by 2027’ Increasing instances of strategic collaborations, aimed at enhancement of R&D for improved therapeutics has created abundant growth opportunities in the market. Technological progress in diagnostic platforms is likely to introduce advanced and upgraded versions of IVD tools for the advanced treatment of infectious diseases. Key players in the market include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG and Thermo Fisher Scientific. The detailed segments and sub-segment of the market are explained as follows By Product & Service segmented into Assays, Kits, & Reagents, Instruments and Services and Software. By Disease Type segmented into Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza and Other Diseases. By Technology segmented into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays and Other Technologies. By End User segmented into Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes and Other End Users.
In spite of significant improvements in sanitation practices and medicine, the global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high, which drives the market. According to NCBI, Worldwide, 17 million HIV-infected people are receiving these life-extending drugs-an impressive number given that only 2.2 million people were on ART in 2005. Medicare has revised its mechanism for reimbursement of some IVD tests, including molecular infectious disease tests. Some of these molecular pathology tests do not have their own HCPCS (Healthcare Common Procedure Coding System) codes, but are charged using unlisted codes, which is the restraining factor. Reimbursement for In Vitro Diagnostic (IVD) Tests examine the U.S. reimbursement system for IVD testing, which focuses on key issues of industry concern. It covers only commercialized tests, excluding those used primarily for research or developmental purposes.
The regional analysis of global infectious disease test the device market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World North America accounted for a share of just over 44.0 percent of the global market in 2019, and it is expected that this trend will continue through the forecast period. This is due too high levels of awareness among practitioners and patients, proactive government initiatives and the presence of sophisticated health care infrastructure. Asia Pacific is expected to register the highest CAGR, driven by favorable government initiatives for infectious disease testing, high unmet medical needs, economic development and consequent rise in disposable income, and increased healthcare spending in emerging countries such as China, India, and South Korea.
The increasing burden of target diseases, rising health awareness, and shift toward self-care clinical devices are projected to drive the market for IVD infectious diseases. Moreover, advancements in IVD kits with improved speed, sensitivity, and patient compliance is anticipated to increase the penetration of IVD kits for diagnosing infectious diseases. Hence, it is anticipated that the market of Global infectious disease test device will boost up throughout the forecast amount.
For More Information on the Research Report, refer to below links: –
Global Infectious Disease Test Device Market Growth
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
